ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS

Clinical trials for ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS trials appear

Sign up with your email to follow new studies for ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat cancers

Disease control Recruiting now

This early-stage study is testing the safety and best dose of a new drug called anvumetostat when given with other cancer therapies. It is for adults with advanced cancers of the digestive system (like pancreatic, stomach, or bile duct cancers) that have a specific genetic change…

Matched conditions: ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS

Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS

Get alerted when new ADVANCED GASTROINTESTINAL, BILIARY TRACT, AND PANCREATIC CANCERS trials appear

New drug combo tested for Tough-to-Treat cancers